Korean Circ J. 2018 Mar;48(3):236-239. English.
Published online Jan 19, 2018.
Copyright © 2018. The Korean Society of Cardiology
Case Report

Isolated Cardiac Sarcoidosis Presenting with Stroke

Masanari Kuwabara, MD, PhD,1,2 Rieko Niitsu Ishimura, MD, PhD,1 Sugao Ishiwata, MD, PhD,1 and Minoru Ohno, MD, PhD1
    • 1Department of Cardiology, Toranomon Hospital, Tokyo, Japan.
    • 2Division of Renal Diseases and Hypertension, University of Colorado Denver, School of Medicine, Aurora, CO, USA.
Received September 21, 2017; Accepted December 14, 2017.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

A 42-year-old man without past medical history presented to our hospital with temporary right sided hemiparalysis and dysarthria. Brain magnetic resonance imaging (MRI) showed multiple cerebrovascular infarctions (Figure 1). Electrocardiography showed sinus rhythm with frequent premature ventricular contractions (PVCs), but no atrial ventricular block. Echocardiography showed partial dyskinesis at the apical lesion and a significant left ventricular (LV) thrombus (Figure 2). Coronary computed tomography angiography (CTA) showed normal coronary arteries (Figure 3). The thrombus became small 4 weeks after anticoagulation therapy with warfarin, but it remained. Therefore, we could not conduct cardiac tissue biopsy because of the additional stroke risks. Gallium-67 scintigraphy showed no specific lesion (Figure 4). However, cardiac MRI showed multiple focal late gadolinium enhancement (LGE) in left ventricle (Figure 5B) where T2 star weighted image (T2WI) also showed pale high intensity (Figure 5A). It suggested active inflammation. Fasting 18F-fluorodeoxyglucose positron emission tomography (PET) after carbohydrate restriction showed multiple increased cardiac uptake lesions (Figure 6). However, apical lesions showed low uptake, which suggests scar lesions. CTA showed normal coronary arteries but cardiac MRI and PET showed multiple focal lesions, which suggests perfusion-metabolism mismatch. In these results, we diagnosed him with isolated cardiac sarcoidosis and started treatment with 30 mg/day (0.5 mg/kg/day) of prednisone.1) The cardiac function improved by echocardiography, the number of PVCs became half in 24-hour Holter electrocardiogram, and follow-up PET image showed less cardiac uptake 3 months after treatment.

Figure 1
Brain magnetic resonance image. This image shows multiple cerebrovascular infarctions especially in the cerebellum.

Figure 2
Echocardiography shows LV thrombus. The thorombus is 2.64×1.74 cm in the LV apical lesion.

LV = left ventricular.

Figure 3
Coronary CTA. This image shows normal coronary arteries.

CTA = computed tomography angiography.

Figure 4
Gallium-67 scintigraphy. This image shows no specific lesion in the body.

Figure 5
Cardiac MRI image. (A) T2WI and (B) LGE image. There are multiple focal LGEs in left ventricle (B) where T2WI also shows pale high intensity with unclear margin. It suggests active inflammation.

LGE = late gadolinium enhancement; MRI = magnetic resonance imaging; T2WI = T2 star weighted image.

Figure 6
Fasting 18F-fluorodeoxyglucose PET. The image shows multiple increased cardiac uptake lesions, especially at the anterior, basal lateral, and inferior LV lesions. The contrast is clear, and the lesions are very similar to LGE lesions. However, apical lesions show low uptake, which suggests scar lesions.

LGE = late gadolinium enhancement; LV = left ventricular; PET = positron emission tomography.

Some cases of systematic sarcoidosis presenting with stroke or heart failure were reported,2), 3) but our case is an isolated cardiac sarcoidosis presented with stroke. Cardiac MRI and PET are useful tools to diagnose isolated cardiac sarcoidosis.4) We should consider isolated cardiac sarcoidosis as a cause of stroke. A study showed that patients with definite cardiac sarcoidosis treated with steroids had better outcome than those with probable cardiac sarcoidosis without treatment.5) This case report suggests that early treatment for isolated cardiac sarcoidosis could be effective.

Notes

Conflict of Interest:The authors have no financial conflicts of interest.

Author Contributions:

  • Conceptualization: Kuwabara M, Niitsu Ishimura R, Ishiwata S, Ohno M.

  • Data curation: Kuwabara M, Niitsu Ishimura R.

  • Formal analysis: Kuwabara M, Niitsu Ishimura R.

  • Investigation: Kuwabara M.

  • Methodology: Kuwabara M, Ishiwata S, Ohno M.

  • Project administration: Kuwabara M.

  • Resources: Kuwabara M, Niitsu Ishimura R.

  • Software: Kuwabara M, Niitsu Ishimura R.

  • Supervision: Kuwabara M, Niitsu Ishimura R.

  • Validation: Kuwabara M, Niitsu Ishimura R, Ishiwata S, Ohno M.

  • Visualization: Kuwabara M.

  • Writing - original draft: Kuwabara M.

  • Writing - review & editing: Kuwabara M, Niitsu Ishimura R, Ishiwata S, Ohno M.

References

    1. Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol 2013;29:1034–1041.
    1. Brown MM, Thompson AJ, Wedzicha JA, Swash M. Sarcoidosis presenting with stroke. Stroke 1989;20:400–405.
    1. White J, Sutton T, Kerr A. Isolated primary cardiac sarcoidosis: MRI diagnosis and monitoring of treatment response with cardiac enzymes. Circ Heart Fail 2010;3:e28–9.
    1. Isobe M, Tezuka D. Isolated cardiac sarcoidosis: clinical characteristics, diagnosis and treatment. Int J Cardiol 2015;182:132–140.
    1. Takaya Y, Kusano KF, Nakamura K, Ito H. Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis. Am J Cardiol 2015;115:1293–1297.

Metrics
Share
Figures

1 / 6

PERMALINK